Whereas 74% patients have these distinctive features (5), the severity of CED varies from mild to severe, so a definite diagnosis relies on detecting the pathogenic variant in the TGFB1 gene by the genetic test. This evidence concerns the gene TGFB1 and cranioectodermal dysplasia.